SQOR and cancer: The effect of SQOR in pan-cancer on the prognosis of tumor patients was further explored, and the results showed that SQOR was a prognostic risk factor in PDAC, liver hepatocellular carcinoma, brain lower grade glioma, lung adenocarcinoma, and uveal melanoma (UVM) (Figure 4G).